Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $4.0250 (-11.83%) ($4.0250 - $4.0250) on Fri. Aug. 26, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 10.79% (three month average) | RSI | 61 | Latest Price | $4.0250(-11.83%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -2% a day on average for past five trading days. | Weekly Trend | ATRA declines -5.1% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) PAVE(96%) XLK(99%) SPY(96%) XLC(90%) IWF(88%) | Factors Impacting ATRA price | ATRA will decline at least -5.395% in a week (0% probabilities). OIH(38%) UUP(-40%) TIP(-16%) USO(-8%) SHY(14%) | | | | | Relative Volatility | | | | Market Trend Strength | -5.395% (StdDev 10.79%) | Hourly BBV | -1.9 () | Intraday Trend | 0% | | | |
|
Resistance Level | $4.3 | 5 Day Moving Average | $4.32(-6.83%) | 10 Day Moving Average | $4.56(-11.73%) | 20 Day Moving Average | $4.3(-6.4%) | To recent high | -54.2% | To recent low | 41% | Market Cap | $299m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |